These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 21999698)

  • 1. Substance-induced psychoses: a critical review of the literature.
    Fiorentini A; Volonteri LS; Dragogna F; Rovera C; Maffini M; Mauri MC; Altamura CA
    Curr Drug Abuse Rev; 2011 Dec; 4(4):228-40. PubMed ID: 21999698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance-Induced Psychoses: An Updated Literature Review.
    Fiorentini A; Cantù F; Crisanti C; Cereda G; Oldani L; Brambilla P
    Front Psychiatry; 2021; 12():694863. PubMed ID: 35002789
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: A systematic review.
    Wilson L; Szigeti A; Kearney A; Clarke M
    Schizophr Res; 2018 Jul; 197():78-86. PubMed ID: 29117908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of sex on substance use between first episode psychosis patients and healthy people.
    Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
    Compr Psychiatry; 2016 Aug; 69():169-78. PubMed ID: 27423358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance-induced psychotic disorders: 13-year data from a de-addiction centre and their clinical implications.
    Aggarwal M; Banerjee A; Singh SM; Mattoo SK; Basu D
    Asian J Psychiatr; 2012 Sep; 5(3):220-4. PubMed ID: 22981049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses.
    Caton CL; Drake RE; Hasin DS; Dominguez B; Shrout PE; Samet S; Schanzer B
    Arch Gen Psychiatry; 2005 Feb; 62(2):137-45. PubMed ID: 15699290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
    Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
    Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is there a temporal correlation between substance abuse and psychosis in adolescents?].
    Holtmann M; Becker K; Hartmann M; Schmidt MH
    Z Kinder Jugendpsychiatr Psychother; 2002 May; 30(2):97-103. PubMed ID: 12053879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary psychosis with comorbid drug abuse and drug-induced psychosis: Diagnostic and clinical evolution at follow up.
    Mauri MC; Di Pace C; Reggiori A; Paletta S; Colasanti A
    Asian J Psychiatr; 2017 Oct; 29():117-122. PubMed ID: 29061407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating first episode substance induced and primary psychotic disorders with concurrent substance use in young people.
    Fraser S; Hides L; Philips L; Proctor D; Lubman DI
    Schizophr Res; 2012 Apr; 136(1-3):110-5. PubMed ID: 22321667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in associations between cannabis and stimulant disorders in first admission psychosis.
    Sara G; Burgess P; Malhi GS; Whiteford H; Hall W
    Schizophr Res; 2013 Jul; 147(2-3):216-22. PubMed ID: 23684162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dually diagnosed patient with psychotic symptoms.
    Ries RK
    J Addict Dis; 1993; 12(3):103-22. PubMed ID: 8251538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Onset of Substance-Induced Psychotic Disorder and Its Progression to Schizophrenia in a Swedish National Sample.
    Kendler KS; Ohlsson H; Sundquist J; Sundquist K
    Am J Psychiatry; 2019 Sep; 176(9):711-719. PubMed ID: 31055966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness?
    Dalmau A; Bergman B; Brismar B
    Eur Psychiatry; 1999 Nov; 14(7):366-71. PubMed ID: 10683620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenomenologic comparison of the idiopathic psychosis of schizophrenia and drug-induced cocaine and phencyclidine psychoses: a retrospective study.
    Rosse RB; Collins JP; Fay-McCarthy M; Alim TN; Wyatt RJ; Deutsch SI
    Clin Neuropharmacol; 1994 Aug; 17(4):359-69. PubMed ID: 9316684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute psychosis induced by psychotomimetic drug abuse. I. Clinical findings.
    Bowers MB
    Arch Gen Psychiatry; 1972 Oct; 27(4):437-40. PubMed ID: 5072710
    [No Abstract]   [Full Text] [Related]  

  • 18. Characteristics and outcomes of young people with substance induced psychotic disorder.
    O'Connell J; Sunwoo M; McGorry P; O'Donoghue B
    Schizophr Res; 2019 Apr; 206():257-262. PubMed ID: 30471979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cannabis and psychosis: search of a causal link through a critical and systematic review].
    Le Bec PY; Fatséas M; Denis C; Lavie E; Auriacombe M
    Encephale; 2009 Sep; 35(4):377-85. PubMed ID: 19748375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Addiction and schizophrenia. Nosological, clinical and therapeutic questions. 2. Substance dependence and schizophrenia].
    Soyka M
    Fortschr Neurol Psychiatr; 1994 Jun; 62(6):186-96. PubMed ID: 8050773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.